1. Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
- Author
-
Dirk Jan A.R. Moes, Peter Pickkers, David M. Burger, K.P. van Rhee, A. Vermeulen Windsant van Den Tweel, J.C. Rahamat-Langedoen, J. van Paassen, Tim Frenzel, R R J van Kimmenade, Jeroen Schouten, M.M. van Rossum, R. ter Heine, P.D. van der Linden, Q. de Mast, R. van Raalte, Florens Polderman, Monique H. Reijers, N.E. Van 't Veer, F.L. van de Veerdonk, T.C.D. Rettig, Roger J. M. Brüggemann, Birgit C. P. Koch, and Pharmacy
- Subjects
Microbiology (medical) ,Male ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Long QT syndrome ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Article ,Prolonged QTc ,Electrocardiography ,Pharmacotherapy ,SDG 3 - Good Health and Well-being ,Chloroquine ,Internal medicine ,Medicine ,Humans ,Pharmacology (medical) ,Aged ,medicine.diagnostic_test ,business.industry ,SARS-CoV-2 ,Other Research Radboud Institute for Health Sciences [Radboudumc 0] ,General Medicine ,Middle Aged ,medicine.disease ,COVID-19 Drug Treatment ,Long QT Syndrome ,lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,Infectious Diseases ,Inflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5] ,Female ,business ,medicine.drug - Abstract
Contains fulltext : 232391.pdf (Publisher’s version ) (Closed access)
- Published
- 2021